<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2023.14159</article-id>
<article-id pub-id-type="publisher-id">OL-27-1-14159</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and validation of a nomogram based on CT texture analysis for discriminating minimally invasive adenocarcinoma from glandular precursor lesions in sub‑centimeter pulmonary ground glass nodules</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Cheng</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref>
<xref rid="fn1-ol-27-1-14159" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Jin</surname><given-names>Yabin</given-names></name>
<xref rid="af2-ol-27-1-14159" ref-type="aff">2</xref>
<xref rid="fn1-ol-27-1-14159" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Deng</surname><given-names>Qi</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yunjun</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Duan</surname><given-names>Rui</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Jiabao</given-names></name>
<xref rid="af3-ol-27-1-14159" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Aizhen</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Gao</surname><given-names>Mingyong</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Zhifeng</given-names></name>
<xref rid="af1-ol-27-1-14159" ref-type="aff">1</xref>
<xref rid="c1-ol-27-1-14159" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-ol-27-1-14159"><label>1</label>Department of Radiology, The First People&#x0027;s Hospital of Foshan, Foshan, Guangdong 528000, P.R. China</aff>
<aff id="af2-ol-27-1-14159"><label>2</label>Clinical Research Institute, The First People&#x0027;s Hospital of Foshan, Foshan, Guangdong 528000, P.R. China</aff>
<aff id="af3-ol-27-1-14159"><label>3</label>Department of Internal Medicine, The Fifth People&#x0027;s Hospital of Nanhai District of Foshan, Foshan, Guangdong 528231, P.R. China</aff>
<author-notes>
<corresp id="c1-ol-27-1-14159"><italic>Correspondence to</italic>: Dr Zhifeng Xu, Department of Radiology, The First People&#x0027;s Hospital of Foshan, 81 Lingnan Avenue North, Chancheng, Foshan, Guangdong 528000, P.R. China, E-mail: <email>jinying@zjcc.org.cn xuzf83@126.com </email></corresp>
<fn id="fn1-ol-27-1-14159"><label>&#x002A;</label><p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="collection">
<month>01</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2023</year></pub-date>
<volume>27</volume>
<issue>1</issue>
<elocation-id>26</elocation-id>
<history>
<date date-type="received"><day>09</day><month>07</month><year>2023</year></date>
<date date-type="accepted"><day>03</day><month>11</month><year>2023</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Li et al.</copyright-statement>
<copyright-year>2023</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>In a recent reclassification, adenocarcinoma <italic>in situ</italic> has been redefined as a glandular precursor lesion (GPL), alongside adenomatous hyperplasia. This updated classification necessitates corresponding adaptations in clinical diagnostic and therapeutic protocols. Consequently, the present study aimed to construct and validate a nomogram utilizing computed tomography (CT) texture features to effectively discriminate between minimally invasive adenocarcinoma (MIA) and GPL within sub-centimeter pulmonary ground glass nodules (GGNs). To achieve this objective, the present study employed rigorous statistical methodologies, including the Mann-Whitney U test and binary logistic regression analysis, to identify distinguishing features and establish predictive models. Subsequently, the diagnostic performance of these models underwent evaluation through receiver operating characteristic (ROC) curves. The area under the curve (AUC) in ROC curves was compared using DeLong&#x0027;s test. Additionally, the nomogram was constructed using R software and its diagnostic performance was validated through calibration curves. Within both the training and validation datasets, the AUCs were observed to be 0.992 [95&#x0025; confidence interval (CI): 0.980&#x2013;1.000] and 0.975 (95&#x0025; CI: 0.935&#x2013;1.000), respectively. DeLong&#x0027;s test revealed significant disparities in the AUCs between the nomogram and single-parameter models (P&#x003C;0.001). Furthermore, calibration curves demonstrated concordance between the training and validation datasets. In conclusion, the application of a CT texture-based nomogram model has demonstrated aptitude in differentiating between MIA and GPL within sub-centimeter GGNs. This model streamlines the identification of optimal surgical interventions and enhances the sphere of clinical decision-making and management.</p>
</abstract>
<kwd-group>
<kwd>computed tomography texture analysis</kwd>
<kwd>adenomatous hyperplasia</kwd>
<kwd>adenocarcinoma <italic>in situ</italic></kwd>
<kwd>minimally invasive adenocarcinoma</kwd>
<kwd>nomogram</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Project of Foshan Science and Technology Bureau</funding-source>
<award-id>2220001003972</award-id>
</award-group>
<award-group>
<funding-source>Science Innovative Project of Foshan</funding-source>
<award-id>FSOAA-KJ218-1301-0021</award-id>
</award-group>
<award-group>
<funding-source>Foshan 14th Five-Year Plan Key Discipline Foundation</funding-source>
<award-id>FSGSP145036</award-id>
</award-group>
<award-group>
<funding-source>Medical Research Subject of Foshan Health Bureau</funding-source>
<award-id>20230027</award-id>
</award-group>
<award-group>
<funding-source>Medical Research Foundation of Guangdong Province</funding-source>
<award-id>A2021493</award-id>
<award-id>A2022330</award-id>
</award-group>
<award-group>
<funding-source>Natural Science Foundation of Guangdong Province</funding-source>
<award-id>2021A1515220032</award-id>
</award-group>
<funding-statement>The present study was supported by Project of Foshan Science and Technology Bureau (grant no. 2220001003972), the Science Innovative Project of Foshan (grant no. FSOAA-KJ218-1301-0021), the Foshan 14th Five-Year Plan Key Discipline Foundation (grant no. FSGSP145036), the Medical Research Subject of Foshan Health Bureau (grant no. 20230027), the Medical Research Foundation of Guangdong Province (grant nos. A2021493 and A2022330) and the Natural Science Foundation of Guangdong Province (grant no. 2021A1515220032).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The incidence and mortality rates of lung cancer surpass those of all other malignant tumors, accounting for &#x007E;20&#x0025; of cancer-related deaths worldwide (<xref rid="b1-ol-27-1-14159" ref-type="bibr">1</xref>). Early diagnosis and treatment are pivotal in improving the prognosis and survival rates of lung cancer patients. In the 2021 WHO classification (<xref rid="b2-ol-27-1-14159" ref-type="bibr">2</xref>), adenocarcinoma <italic>in situ</italic> (AIS) has been reclassified as a glandular precursor lesion (GPL) along with adenomatous hyperplasia (AAH), while the subcategories of lung cancer now include minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC). This classification update necessitates corresponding adjustments to clinical diagnosis and treatment protocols. Currently, management follow-up strategies predominantly apply to AAH and AIS, whereas MIA warrants prompt surgical intervention (<xref rid="b3-ol-27-1-14159" ref-type="bibr">3</xref>,<xref rid="b4-ol-27-1-14159" ref-type="bibr">4</xref>). Furthermore, although some studies have indicated comparable long-term efficacy and 5-year survival rates between AAH, AIS and MIA surgeries, others have found that MIA exhibits higher Ki67 levels and EGFR mutation rates compared with AIS (<xref rid="b5-ol-27-1-14159" ref-type="bibr">5</xref>). Therefore, achieving precise discrimination of MIA from GPL during management follow-up and pre-surgical stages provides important insights for determining optimal clinical intervention timing, implementing surgical protocols and assessing prognosis.</p>
<p>Previous studies have demonstrated that high-resolution low-dose computed tomography (CT) is currently the most effective screening tool, reducing lung cancer mortality by 20&#x0025; (<xref rid="b6-ol-27-1-14159" ref-type="bibr">6</xref>). Over 90&#x0025; of these cases represent early-stage lung cancer, with pulmonary ground glass nodules (GGNs) being the primary manifestation on CT scans. While pathological biopsy serves as the gold standard for diagnosing lung cancer types, frozen section analysis has emerged as a valuable method for rapid intraoperative assessment of nodules, distinguishing between benign and malignant lesions and determining histological subtypes. This information plays a crucial role in guiding surgical strategies for lung nodules (<xref rid="b7-ol-27-1-14159" ref-type="bibr">7</xref>,<xref rid="b8-ol-27-1-14159" ref-type="bibr">8</xref>). However, due to the small size and low density of lung nodules, sampling often yields suboptimal results, resulting in a concordance rate of only &#x007E;68&#x0025; between intraoperative frozen section analysis and postoperative paraffin pathology (<xref rid="b8-ol-27-1-14159" ref-type="bibr">8</xref>). Some researchers have explored the use of traditional CT imaging features (such as nodule size, density and solid component proportion) to differentiate between MIA and GPL (<xref rid="b9-ol-27-1-14159" ref-type="bibr">9</xref>,<xref rid="b10-ol-27-1-14159" ref-type="bibr">10</xref>). However, these features exhibit significant overlap across different nodule subtypes, leading to low diagnostic efficacy (<xref rid="b11-ol-27-1-14159" ref-type="bibr">11</xref>). Moreover, the extraction of these features heavily relies on the subjective interpretation skills and clinical experience of the radiologist (<xref rid="b8-ol-27-1-14159" ref-type="bibr">8</xref>). In addition, traditional techniques often struggle to identify nodules with smaller volumes and mixed densities. The increasing prevalence of GGNs with diameters &#x003C;10 mm, detected through low-dose CT screening for early lung cancer, presents new challenges in clinical diagnosis. Some studies have proposed a critical value of 10 mm diameter for distinguishing between glandular precursor lesions and invasive lesions (<xref rid="b9-ol-27-1-14159" ref-type="bibr">9</xref>,<xref rid="b10-ol-27-1-14159" ref-type="bibr">10</xref>,<xref rid="b12-ol-27-1-14159" ref-type="bibr">12</xref>). Nevertheless, clinical practice has revealed numerous GGNs &#x2264;10mm confirmed as MIA or IAC (<xref rid="b10-ol-27-1-14159" ref-type="bibr">10</xref>), leading to continuing debates about the management strategies for GGNs of this size (<xref rid="b13-ol-27-1-14159" ref-type="bibr">13</xref>). Consequently, there is an urgent need for innovative and accurate techniques to enable the precise preoperative diagnosis of MIA and GPL.</p>
<p>Radiomics is a powerful technique that enables the extraction and analysis of numerous radiomics features from medical imaging data with high efficiency. This approach holds significant promise in distinguishing between different pathological subcategories of lung nodules, assessing the extent of infiltration and evaluating prognostic outcomes (<xref rid="b14-ol-27-1-14159" ref-type="bibr">14</xref>). Texture analysis, on the other hand, involves the extraction and quantitative analysis of non-macroscopic and deep-level CT image features that reflect the tumor&#x0027;s heterogeneity to some extent. It has demonstrated utility in various aspects, including tumor differential diagnosis, prognostic evaluation, treatment response prediction and monitoring (<xref rid="b15-ol-27-1-14159" ref-type="bibr">15</xref>&#x2013;<xref rid="b17-ol-27-1-14159" ref-type="bibr">17</xref>). CT texture analysis is widely utilized for identifying benign and malignant solitary lung nodules and evaluating invasiveness, exhibiting exceptional performance (<xref rid="b18-ol-27-1-14159" ref-type="bibr">18</xref>,<xref rid="b19-ol-27-1-14159" ref-type="bibr">19</xref>). To date, there have been no reports on the application of texture analysis for the identification of MIA and GPL in sub-centimeter GGNs. Therefore, the present study aimed to develop and validate a nomogram based on CT quantitative parameters and texture features for improving the ability to discriminate MIA from AAH/AIS, thereby providing important guidance for formulating clinical treatment plans and optimizing the timing of surgical interventions.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Patient and nodule selection</title>
<p>The present retrospective study received approval from the ethics committee and written informed consent was waived. Patients with sub-centimeter GGNs who underwent high-resolution CT (HRCT) were enrolled at the First People&#x0027;s Hospital of Foshan between January 2019 and February 2022. The flowchart illustrating patient inclusion and exclusion is shown in <xref rid="f1-ol-27-1-14159" ref-type="fig">Fig. 1</xref>, which was in accordance with previous studies (<xref rid="b17-ol-27-1-14159" ref-type="bibr">17</xref>,<xref rid="b19-ol-27-1-14159" ref-type="bibr">19</xref>,<xref rid="b20-ol-27-1-14159" ref-type="bibr">20</xref>). The inclusion criteria were as follows: i) GGNs with a maximum diameter &#x2264;10 mm, evaluated using lung window settings [level: &#x2212;600 Hounsfield units (HU); width: 1,500 HU]; ii) confirmation of AAH, AIS or MIA through surgical excision and pathology examination referring to the 2021 WHO classification (<xref rid="b2-ol-27-1-14159" ref-type="bibr">2</xref>); iii) availability of chest HRCT examination conducted within one month prior to surgical treatment; iv) absence of prior history of puncture, chemotherapy, or radiotherapy; v) absence of lung cancer or other malignant tumors. The exclusion criteria consisted of: i) inability to accurately delineate the region of interest due to the presence of artifacts or other lesions; ii) inaccurate identification or segmentation of CT images, including incomplete delineation or failure to avoid blood vessels, bronchi, pleura and other structures. The final selected cases were divided into two groups: 49 cases with AAH/AIS and 62 cases with MIA. The recruited patients were randomly assigned to a training set (78 nodules) and a validation set (33 nodules) at a ratio of 7:3.</p>
</sec>
<sec>
<title>CT image acquisition</title>
<p>The CT examinations for all patients included in the study were conducted using Philips CT scanners: the Philips Ingenuity 64-slice CT scanner (Philips Medical Systems, Inc.) and the Philips Brilliance iCT 256-slice CT scanner (Philips Ultrasound, Inc.). The patients were positioned in the supine (lying face-up) posture and the scanning range extended from the apex to the base of the lungs. Scans were performed at the end of a deep inspiration, followed by breath-holding to ensure stability. A tube voltage of 120 kV was used and the tube current employed automatic milliamp-second technology. The pitch value was set to 1.0, the collimation was 0.625&#x00D7;1.25 mm and the field of view (FOV) was set to 350&#x00D7;350 mm, with a pixel size of 512&#x00D7;512. The acquired images were reconstructed using both the standard algorithm and the high-resolution algorithm. The reconstructed slices had a thickness of 1 mm and a spacing of 1 mm.</p>
</sec>
<sec>
<title>CT image segmentation and feature extraction</title>
<p>The CT images in DICOM format were imported into the uAI-ChestCare software (version 0130; Shanghai United Imaging Healthcare Co., Ltd.), which was used for image segmentation and extraction of texture features (<xref rid="b20-ol-27-1-14159" ref-type="bibr">20</xref>,<xref rid="b21-ol-27-1-14159" ref-type="bibr">21</xref>). This software facilitated the automatic delineation of the complete 3D region of interest (ROI) for the identified lesions by outlining the tumor boundary on consecutive axial lung window images (with a window width of 1,500 HU and a window level of &#x2212;600 HU). Subsequently, various quantitative and texture features were computed, encompassing maximum diameter (MD), solid volume (SV), solid volume rate (SVR), solid quality (SQ), solid quality rate (SQR), maximum computed tomography attenuation (CT<sub>max</sub>), minimum computed tomography attenuation (CT<sub>min</sub>), mean computed tomography attenuation (CT<sub>mean</sub>), median computed tomography attenuation (CT<sub>median</sub>), variance, kurtosis, skewness and entropy. To evaluate the accuracy of the software&#x0027;s automated nodule delineation, two radiologists with over 10 years of experience in thoracic imaging diagnosis independently assessed the results. They excluded cases where the nodule contour was incomplete or where blood vessels, bronchi, pleura and similar structures were not properly avoided. In instances where disagreements arose regarding the exclusion of certain cases, they negotiated to precisely delineate nodule boundaries while avoiding the inclusion of bronchi, large vessels, vacuole and normal tissue beyond the pleura in accordance with previous studies (<xref rid="b22-ol-27-1-14159" ref-type="bibr">22</xref>,<xref rid="b23-ol-27-1-14159" ref-type="bibr">23</xref>). A senior physician with 15 years of experience in thoracic imaging diagnosis verified the preceding two radiologists&#x0027; segmentation results and provided the final confirmation of the results (<xref rid="b19-ol-27-1-14159" ref-type="bibr">19</xref>). The CT quantitative and texture features extraction of AIS (<xref rid="f2-ol-27-1-14159" ref-type="fig">Fig. 2A</xref>) and MIA (<xref rid="f2-ol-27-1-14159" ref-type="fig">Fig. 2B</xref>) were taken as examples.</p>
</sec>
<sec>
<title>Nomogram model building</title>
<p>The clinical, CT quantitative and texture features of both the training and validation groups were subjected to analysis using the Mann-Whitney U test to identify the effective distinguishing features. Subsequently, binary logistic regression analysis was employed to develop both a single-parameter model and a combined multi-parameter nomogram model. The diagnostic performance of these prediction models was assessed through the construction of receiver operating characteristic (ROC) curves (<xref rid="b24-ol-27-1-14159" ref-type="bibr">24</xref>) and the comparison of area under the curve (AUC) of ROC curves was performed using DeLong&#x0027;s test (<xref rid="b25-ol-27-1-14159" ref-type="bibr">25</xref>). Furthermore, the construction of the nomogram was accomplished using the rms package in the R software (version 4.0, R Foundation; <uri xlink:href="https://www.Rproject.org">http://www.Rproject.org</uri>). To evaluate the diagnostic performance of the nomogram prediction model, a calibration curve was employed.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The statistical analysis was conducted using SPSS version 20 software (IBM Corp.). Continuous variables were summarized as mean &#x00B1; standard deviation (SD) or median with the full range. Categorical variables were presented as frequencies and percentages. Differences in age and sex between the two groups were assessed using the independent sample t-test and the &#x03C7;<sup>2</sup> test, respectively. To identify significant variables as predictive indicators of MIA the Mann-Whitney U test was applied based on the CT quantitative and texture features. Variables with a significance level of P&#x003C;0.05 were selected as significant predictors for constructing both single-parameter and combined multi-parameter prediction models through binary logistic regression analysis. The diagnostic performance of each model was then evaluated by comparing the AUC, specificity and sensitivity of the ROC curve. AUC values greater than 0.5 were considered predictive. The significance of differences between ROC curves was determined using DeLong&#x0027;s test. Furthermore, the nomogram was constructed using the rms package in the R software. To verify the diagnostic performance of the nomogram prediction model, a calibration curve was employed. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Patient characteristics</title>
<p>A total of 109 patients with 111 GGNs were ultimately included in the present study. The cohort consisted of 35 males and 74 females, with ages ranging 19&#x2013;78 years. Among these patients, 49 GGNs in 47 patients were classified as GPL (AAH/AIS), with a mean age of (54.26&#x00B1;12.24) years. Additionally, 62 GGNs in 62 patients were categorized as MIA, with a mean age of (52.84&#x00B1;11.47) years. There were no significant differences observed in terms of sex (P=0.564) or age (P=0.522) between the two groups. Utilizing stratified random sampling, the training set consisted of 78 cases (34 AAH/AIS and 44 MIA), while the validation set included 33 cases (15 AAH/AIS and 18 MIA).</p>
</sec>
<sec>
<title>CT quantitative parameters and texture feature extraction</title>
<p>The results of patient characteristics, CT quantitative parameters and texture features were conducted using the Mann-Whitney U test and the results are presented in <xref rid="tI-ol-27-1-14159" ref-type="table">Table I</xref>. Notably, significant statistical differences (P&#x003C;0.05) were observed between the two groups in seven parameters, including SV, SVR, SQ, SQR, CT<sub>max</sub>, CT<sub>mean</sub> and entropy.</p>
</sec>
<sec>
<title>Model construction and diagnostic validation based on CT quantitative parameters and texture features</title>
<p>The diagnostic models were constructed and the corresponding ROC curves are displayed in <xref rid="f3-ol-27-1-14159" ref-type="fig">Fig. 3</xref>. Notably, the combined multi-parameter model exhibited superior predictive ability compared with each individual single-parameter model. The performance of the nomogram prediction model is illustrated in <xref rid="tII-ol-27-1-14159" ref-type="table">Table II</xref> for the training set and <xref rid="tIII-ol-27-1-14159" ref-type="table">Table III</xref> for the validation set. In the training set, the nomogram achieved an AUC of 0.992 (95&#x0025; CI: 0.980&#x2013;1.000), a sensitivity of 0.907, a specificity of 1.000 and an accuracy of 0.948. For the validation set, the AUC was 0.975 (95&#x0025; CI: 0.935&#x2013;1.000), with a sensitivity of 0.842, a specificity of 0.941 and an accuracy of 0.912. The results of DeLong&#x0027;s test demonstrated significant statistical differences in AUCs between the nomogram and single-parameter models (P&#x003C;0.001).</p>
</sec>
<sec>
<title>Nomogram and calibration curve</title>
<p>A nomogram (<xref rid="f4-ol-27-1-14159" ref-type="fig">Fig. 4A</xref>) was constructed utilizing five parameters (SV, SVR, CT<sub>max</sub>, CT<sub>mean</sub> and entropy). The model formula was derived as follows: Total Points=0.576 &#x00D7; SV &#x2212;1.131 &#x00D7; SVR - 0.162&#x00D7; CT<sub>max</sub> - 0.136 &#x00D7; CT<sub>mean</sub> &#x002B; 21.533 &#x00D7; entropy. Each parameter in the nomogram corresponds to a specific score on the top &#x2018;Points&#x2019; axis. The cumulative sum of these scores corresponds to the values displayed on the bottom &#x2018;Total Points&#x2019; axis, representing the diagnostic probability of MIA: Two cases of AIS and MIA (<xref rid="f4-ol-27-1-14159" ref-type="fig">Fig. 4B and C</xref>) provided illustrative examples from the collected database. The calibration curve (<xref rid="f5-ol-27-1-14159" ref-type="fig">Fig. 5</xref>) demonstrates a favorable agreement between the predicted model and the observed data, as the scatter plot closely aligns with the ideal curve.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The present study retrospectively collected surgically resected and pathologically confirmed cases of GPL and MIA that presented as sub-centimeter GGNs on CT images, then extracted and analyzed their CT quantitative and texture features. Subsequently, a nomogram model incorporating the five most informative identification indicators (SV, SVR, CT<sub>max</sub>, CT<sub>mean</sub> and entropy) was developed to accurately differentiate MIA from GPL. The ROC curve revealed high predictive accuracy in distinguishing between MIA and GPL, with an AUC values of 0.992 and 0.975 for the training set and validation set, respectively. Early-stage lung cancers predominantly present as solitary GGNs, posing challenges in distinguishing benign nodules from malignant ones due to the diverse manifestations and overlapping features observed on CT images. In line with previous studies by Wu <italic>et al</italic> (<xref rid="b9-ol-27-1-14159" ref-type="bibr">9</xref>,<xref rid="b10-ol-27-1-14159" ref-type="bibr">10</xref>), who extensively analyzed the CT imaging features of sub-centimeter pure GGNs, the present study identified relevant morphological features such as lesion size, vessel changes and tumor-lung interface, which reflect the invasiveness of GGNs. Moreover, previous investigations (<xref rid="b26-ol-27-1-14159" ref-type="bibr">26</xref>&#x2013;<xref rid="b28-ol-27-1-14159" ref-type="bibr">28</xref>) have established a close association between the size of the solid component and the average CT attenuation of GGNs with their invasiveness and pathology. The findings of the present study corroborated these conclusions, demonstrating significant differences in SV, SVR, SQ, SQR, CT<sub>max</sub> and CT<sub>mean</sub> between GPL and MIA. Notably, the values of these variables were consistently higher in the MIA group compared with the GPL group. These results confirm the importance of the solid component in predicting the behavior of GGNs. To summarize, the present study retrospectively analyzed surgically resected GGNs, extracting and analyzing their CT quantitative and texture features and achieved high predictive performance in discriminating between MIA and GPL through the development of a nomogram model incorporating five informative identification indicators. The challenges associated with differentiating benign and malignant nodules in early-stage lung cancers were underscored, emphasizing the significance of considering the presence and characteristics of the solid component in predicting invasiveness and pathological behavior of GGNs.</p>
<p>Texture analysis plays a crucial role in efficiently and accurately extracting biological information that reflects tumor heterogeneity, which may not be discernible by visual examination of images alone. It enables quantitative assessment of subtle changes in image pixel values and their arrangement. As a result, it holds great value in qualitative diagnosis, invasiveness assessment, prognostic prediction of tumors and informed clinical management. Qiu <italic>et al</italic> (<xref rid="b17-ol-27-1-14159" ref-type="bibr">17</xref>) demonstrated the independent prognostic significance of mean CT attenuation and entropy in evaluating the invasiveness of 428 cases of clinical stage IA lung adenocarcinoma. Zhu <italic>et al</italic> (<xref rid="b19-ol-27-1-14159" ref-type="bibr">19</xref>) employed the ANOVA test and the least absolute shrinkage and selection operator algorithm to identify 18 CT texture features, including entropy. They successfully developed a diagnostic model capable of distinguishing MIA from GPL presenting as pure GGNs, achieving high identification performance with an AUC of 0.884 in the training set and 0.872 in the validation set. In the present study, there was a statistically significant difference in entropy between GPL and MIA, which is consistent with previous findings. Moreover, the combined multi-parameter model exhibited superior predictive performance, with AUC values of 0.992 in the training set and 0.975 in the validation set, surpassing the research conducted by Zhu <italic>et al</italic> (<xref rid="b19-ol-27-1-14159" ref-type="bibr">19</xref>). This disparity may be attributed to differences in the composition of enrolled cases. The present study encompassed not only pure vitreous nodules but also mixed-density nodules. Previous studies (<xref rid="b26-ol-27-1-14159" ref-type="bibr">26</xref>,<xref rid="b28-ol-27-1-14159" ref-type="bibr">28</xref>) have indicated the diagnostic relevance of the solid component within GGNs. Another study (<xref rid="b29-ol-27-1-14159" ref-type="bibr">29</xref>) employed machine learning and deep learning methods to evaluate benign and malignant pulmonary nodules, revealing AUC values of 0.763 for the support vector machine (SVM) model and 0.723 for the convolutional neural networks (CNN) model in distinguishing GPL from MIA. Notably, the predictive performance of both SVM and CNN models was lower than that of the nomogram model established in the present study. These findings suggest that CT texture analysis may offer greater assistance and efficiency in achieving this objective. The patients in the present study were sourced from a single center, resulting in a relatively small sample size, but the parameters and quality of these CT images were highly standardized and homogenized. Conversely, in a previous multicenter study (<xref rid="b29-ol-27-1-14159" ref-type="bibr">29</xref>), although the sample size was larger, challenges related to CT image homogenization may have persisted. This discrepancy could explain the superior diagnostic effectiveness of the constructed model. Consequently, future studies should focus on expanding the sample size and analyzing data from different centers to obtain a more accurate and efficient predictive model.</p>
<p>Nomogram models are graphical representations employed to illustrate analytical outcomes derived from multifactorial logistic regression models or Cox proportional hazards models. These models use a set of parallel, non-intersecting lines within a coordinate plane to portray the quantitative analysis diagram, depicting the functional relationship between multiple variables. By employing intuitive symbols, nomograms facilitate the calculation of disease occurrence probability, recurrence risk and prognosis. Consequently, they find extensive application in clinical research pertaining to pulmonary GGNs (<xref rid="b30-ol-27-1-14159" ref-type="bibr">30</xref>). In the present study, a nomogram model for the identification of precursor lesions and MIA was established, based on five CT quantitative and texture features, namely SV, SVR, CT<sub>max</sub>, CT<sub>mean</sub> and entropy. This model serves as an effective and intuitive reference standard, enabling radiologists to achieve accurate and prompt diagnoses.</p>
<p>In conclusion, the use of CT quantitative and texture features offered significant utility in the differentiation of MIA from GPL. The nomogram model developed demonstrated superior discriminatory capabilities. This model&#x0027;s diagnostic efficacy, combined with its graphical representation, facilitates the precise classification of GGN types by radiologists, thereby aiding clinicians in making informed decisions regarding treatment and follow-up strategies for GGNs. Nonetheless, the present study has certain limitations that require acknowledgment. It was a retrospective, single-center study with a small sample size, which may introduce selection bias and potentially affect the precision and applicability of the model. In the future, efforts should be made to enhance the model&#x0027;s robustness and applicability by increasing the sample size, conducting multi-center studies and incorporating external test sets.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>CL and ZX participated in the design of the study. YJ and QD performed data analysis and prepared the figures. YY, RD and JZ participated in the analysis of the figures and data. CL and YJ prepared and revised the manuscript. AP, MG and ZX reviewed the results and revised the manuscript. CL, AP, MG and ZX confirm the authenticity of all the raw data. All authors have read and approved the final version of this manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The present study was approved by the Institutional Research Ethics Committee of the First Peoples&#x0027; Hospital of Foshan (approval no. 2021.02) and was conducted in accordance with the ethical principles of the Declaration of Helsinki and the ethical laws and regulations established in China. Written informed consent was waived.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Use of artificial intelligence tools</title>
<p>The uAI-ChestCare software is an artificial intelligence (AI) software based on deep learning method, specifically designed for applications related to chest or pulmonary care and have achieved good results in prior research endeavors. In the present study, CT lung window images, configured with a window width of 1,500 Hounsfield Units (HU) and a window level of &#x2212;600 HU in DICOM format, were input into the uAI-ChestCare software. Subsequently, the software autonomously delineated the entire 3D ROI for identified lesions by outlining the tumor boundaries across consecutive axial slices. Following this, an array of quantitative and textural features were computed, encompassing parameters such as MD, SV, SVR, SQ, SQR, maximum computed tomography attenuation CT<sub>max</sub>, CT<sub>min</sub>, CT<sub>mean</sub>, CT<sub>median</sub>), variance, kurtosis, skewness and entropy.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-ol-27-1-14159"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyldgaard</surname><given-names>C</given-names></name><name><surname>Trolle</surname><given-names>C</given-names></name><name><surname>Harders</surname><given-names>SMW</given-names></name><name><surname>Engberg</surname><given-names>H</given-names></name><name><surname>Rasmussen</surname><given-names>TR</given-names></name><name><surname>M&#x00F8;ller</surname><given-names>H</given-names></name></person-group><article-title>Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: Pathways and patient characteristics</article-title><source>BMC Cancer</source><volume>22</volume><fpage>464</fpage><year>2022</year><pub-id pub-id-type="doi">10.1186/s12885-022-09585-2</pub-id><pub-id pub-id-type="pmid">35477356</pub-id></element-citation></ref>
<ref id="b2-ol-27-1-14159"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>JE</given-names></name><name><surname>Heuvelmans</surname><given-names>MA</given-names></name><name><surname>Bock</surname><given-names>GH</given-names></name><name><surname>Yousaf-Khan</surname><given-names>U</given-names></name><name><surname>Groen</surname><given-names>HJM</given-names></name><name><surname>Aalst</surname><given-names>CMV</given-names></name><name><surname>Nackaerts</surname><given-names>K</given-names></name><name><surname>Ooijen</surname><given-names>PMAV</given-names></name><name><surname>Koning</surname><given-names>HJ</given-names></name><name><surname>Vliegenthart</surname><given-names>R</given-names></name><name><surname>Oudkerk</surname><given-names>M</given-names></name></person-group><article-title>Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: The NELSON study</article-title><source>Thorax</source><volume>73</volume><fpage>741</fpage><lpage>747</lpage><year>2018</year><pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-211376</pub-id><pub-id pub-id-type="pmid">29661918</pub-id></element-citation></ref>
<ref id="b3-ol-27-1-14159"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammemagi</surname><given-names>MC</given-names></name><name><surname>Lam</surname><given-names>S</given-names></name></person-group><article-title>Screening for lung cancer using low dose computed tomography</article-title><source>BMJ</source><volume>348</volume><fpage>g2253</fpage><year>2014</year><pub-id pub-id-type="doi">10.1136/bmj.g2253</pub-id><pub-id pub-id-type="pmid">24865600</pub-id></element-citation></ref>
<ref id="b4-ol-27-1-14159"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Tsao</surname><given-names>MS</given-names></name><name><surname>Beasley</surname><given-names>MB</given-names></name><name><surname>Borczuk</surname><given-names>AC</given-names></name><name><surname>Brambilla</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>WA</given-names></name><name><surname>Dacic</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>D</given-names></name><name><surname>Kerr</surname><given-names>KM</given-names></name><name><surname>Lantuejoul</surname><given-names>S</given-names></name><etal/></person-group><article-title>The 2021 WHO classification of lung tumors: Impact of advances since 2015</article-title><source>J Thorac Oncol</source><volume>17</volume><fpage>362</fpage><lpage>387</lpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.jtho.2021.11.003</pub-id><pub-id pub-id-type="pmid">34808341</pub-id></element-citation></ref>
<ref id="b5-ol-27-1-14159"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lantuejoul</surname><given-names>S</given-names></name><name><surname>Rouquette</surname><given-names>I</given-names></name><name><surname>Brambilla</surname><given-names>E</given-names></name><name><surname>Travis</surname><given-names>WD</given-names></name></person-group><article-title>New WHO classification of lung adenocarcinoma and preneoplasia</article-title><source>Ann Pathol</source><volume>36</volume><fpage>5</fpage><lpage>14</lpage><year>2016</year><comment>(In French)</comment><pub-id pub-id-type="doi">10.1016/j.annpat.2015.11.010</pub-id><pub-id pub-id-type="pmid">26791238</pub-id></element-citation></ref>
<ref id="b6-ol-27-1-14159"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yankelevitz</surname><given-names>DF</given-names></name><name><surname>Yip</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>JP</given-names></name><name><surname>Liang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>DM</given-names></name><name><surname>Salvatore</surname><given-names>MM</given-names></name><name><surname>Wolf</surname><given-names>AS</given-names></name><name><surname>Flores</surname><given-names>RM</given-names></name><name><surname>Henschke</surname><given-names>CI</given-names></name><collab collab-type="corp-author">International Early Lung Cancer Action Program Investigators Group</collab></person-group><article-title>CT screening for lung cancer: Nonsolid nodules in baseline and annual repeat rounds</article-title><source>Radiology</source><volume>277</volume><fpage>555</fpage><lpage>564</lpage><year>2015</year><pub-id pub-id-type="doi">10.1148/radiol.2015142554</pub-id><pub-id pub-id-type="pmid">26101879</pub-id></element-citation></ref>
<ref id="b7-ol-27-1-14159"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>YQ</given-names></name></person-group><article-title>From focal pulmonary pure ground-glass opacity nodule detected by low-dose computed tomography into invasive lung adenocarcinoma: A growth pattern analysis in the elderly</article-title><source>Thorac Cancer</source><volume>9</volume><fpage>1361</fpage><lpage>1365</lpage><year>2018</year><pub-id pub-id-type="doi">10.1111/1759-7714.12829</pub-id><pub-id pub-id-type="pmid">30144287</pub-id></element-citation></ref>
<ref id="b8-ol-27-1-14159"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagami</surname><given-names>T</given-names></name><name><surname>Yoshimatsu</surname><given-names>R</given-names></name><name><surname>Miura</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Takahata</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Hasebe</surname><given-names>T</given-names></name></person-group><article-title>Diagnostic performance of percutaneous lung biopsy using automated biopsy needles under CT-fluoroscopic guidance for ground-glass opacity lesions</article-title><source>Br J Radiol</source><volume>86</volume><fpage>20120447</fpage><year>2013</year><pub-id pub-id-type="doi">10.1259/bjr.20120447</pub-id><pub-id pub-id-type="pmid">23385998</pub-id></element-citation></ref>
<ref id="b9-ol-27-1-14159"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>SP</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Jing</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>YQ</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>SH</given-names></name></person-group><article-title>CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter</article-title><source>Eur Radiol</source><volume>27</volume><fpage>4037</fpage><lpage>4043</lpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s00330-017-4829-5</pub-id><pub-id pub-id-type="pmid">28386719</pub-id></element-citation></ref>
<ref id="b10-ol-27-1-14159"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Cai</surname><given-names>ZL</given-names></name><name><surname>Tian</surname><given-names>SP</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Jing</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>SH</given-names></name></person-group><article-title>Analysis of histopathologic subtypes and CT characteristics of lung adenocarcinomas presenting as pure ground-glass nodule of 1 cm or less in maximal diameter</article-title><source>Chin J Radiol</source><volume>50</volume><fpage>260</fpage><lpage>264</lpage><year>2016</year></element-citation></ref>
<ref id="b11-ol-27-1-14159"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>PL</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name></person-group><article-title>Clinicopathologic Features and genetic alterations in adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: Long-term follow-up study of 121 Asian patients</article-title><source>Ann Surg Oncol</source><volume>27</volume><fpage>3052</fpage><lpage>3063</lpage><year>2020</year><pub-id pub-id-type="doi">10.1245/s10434-020-08241-y</pub-id><pub-id pub-id-type="pmid">32048092</pub-id></element-citation></ref>
<ref id="b12-ol-27-1-14159"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Development and validation of a radiomics nomogram for identifying invasiveness of pulmonary adenocarcinomas appearing as subcentimeter ground-glass opacity nodules</article-title><source>Eur J Radiol</source><volume>112</volume><fpage>161</fpage><lpage>168</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.ejrad.2019.01.021</pub-id><pub-id pub-id-type="pmid">30777206</pub-id></element-citation></ref>
<ref id="b13-ol-27-1-14159"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>HD</given-names></name><name><surname>Park</surname><given-names>CM</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>KG</given-names></name><name><surname>Goo</surname><given-names>JM</given-names></name></person-group><article-title>Computerized texture analysis of persistent part-solid ground-glass nodules: Differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas</article-title><source>Radiology</source><volume>273</volume><fpage>285</fpage><lpage>293</lpage><year>2014</year><pub-id pub-id-type="doi">10.1148/radiol.14132187</pub-id><pub-id pub-id-type="pmid">25102296</pub-id></element-citation></ref>
<ref id="b14-ol-27-1-14159"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>SP</given-names></name><name><surname>Schroeder</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Coquia</surname><given-names>SF</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name></person-group><article-title>Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions: Generation of a predictive model on the basis of quantitative spatial frequency measurements-a work in progress</article-title><source>J Comput Assist Tomogr</source><volume>39</volume><fpage>383</fpage><lpage>395</lpage><year>2015</year><pub-id pub-id-type="pmid">25700222</pub-id></element-citation></ref>
<ref id="b15-ol-27-1-14159"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>F</given-names></name><name><surname>Ganeshan</surname><given-names>B</given-names></name><name><surname>Kozarski</surname><given-names>R</given-names></name><name><surname>Miles</surname><given-names>KA</given-names></name><name><surname>Goh</surname><given-names>V</given-names></name></person-group><article-title>Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: Contrast-enhanced CT texture as a biomarker of 5-year survival</article-title><source>Radiology</source><volume>266</volume><fpage>177</fpage><lpage>184</lpage><year>2013</year><pub-id pub-id-type="doi">10.1148/radiol.12120254</pub-id><pub-id pub-id-type="pmid">23151829</pub-id></element-citation></ref>
<ref id="b16-ol-27-1-14159"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Che</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact</article-title><source>Cancer Imaging</source><volume>21</volume><fpage>1</fpage><year>2021</year><pub-id pub-id-type="doi">10.1186/s40644-020-00376-1</pub-id><pub-id pub-id-type="pmid">33407884</pub-id></element-citation></ref>
<ref id="b17-ol-27-1-14159"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>ZB</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Chu</surname><given-names>XP</given-names></name><name><surname>Cai</surname><given-names>FY</given-names></name><name><surname>Yang</surname><given-names>XN</given-names></name><name><surname>Wu</surname><given-names>YL</given-names></name><name><surname>Zhong</surname><given-names>WZ</given-names></name></person-group><article-title>Quantifying invasiveness of clinical stage IA lung adenocarcinoma with computed tomography texture features</article-title><source>J Thorac Cardiovasc Surg</source><volume>163</volume><fpage>805</fpage><lpage>815</lpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.jtcvs.2020.12.092</pub-id><pub-id pub-id-type="pmid">33541730</pub-id></element-citation></ref>
<ref id="b18-ol-27-1-14159"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>Y</given-names></name><name><surname>Sung</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Sim</surname><given-names>SB</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name></person-group><article-title>Pure ground-glass opacity on chest computed tomography: Predictive factors for invasive adenocarcinoma</article-title><source>J Thorac Dis</source><volume>8</volume><fpage>1561</fpage><lpage>1570</lpage><year>2016</year><pub-id pub-id-type="doi">10.21037/jtd.2016.06.34</pub-id><pub-id pub-id-type="pmid">27499944</pub-id></element-citation></ref>
<ref id="b19-ol-27-1-14159"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YQ</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Mo</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Duan</surname><given-names>YN</given-names></name><name><surname>Tang</surname><given-names>LL</given-names></name><name><surname>Chu</surname><given-names>YY</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name></person-group><article-title>Radiomics for differentiating minimally invasive adenocarcinoma from precursor lesions in pure ground-glass opacities on chest computed tomography</article-title><source>Br J Radiol</source><volume>95</volume><fpage>20210768</fpage><year>2022</year><pub-id pub-id-type="doi">10.1259/bjr.20210768</pub-id><pub-id pub-id-type="pmid">35262392</pub-id></element-citation></ref>
<ref id="b20-ol-27-1-14159"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Qing</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name></person-group><article-title>Development and validation of qualitative and quantitative models to predict invasiveness of lung adenocarcinomas manifesting as pure ground-glass nodules based on low-dose computed tomography during lung cancer screening</article-title><source>Quant Imaging Med Surg</source><volume>12</volume><fpage>2917</fpage><lpage>2931</lpage><year>2022</year><pub-id pub-id-type="doi">10.21037/qims-21-912</pub-id><pub-id pub-id-type="pmid">35502397</pub-id></element-citation></ref>
<ref id="b21-ol-27-1-14159"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name></person-group><article-title>Semi-supervised adversarial model for benign-malignant lung nodule classification on chest CT</article-title><source>Med Image Anal</source><volume>57</volume><fpage>237</fpage><lpage>248</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.media.2019.07.004</pub-id><pub-id pub-id-type="pmid">31352126</pub-id></element-citation></ref>
<ref id="b22-ol-27-1-14159"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Xiang</surname><given-names>P</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Pang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name></person-group><article-title>CT-imaging based analysis of invasive lung adenocarcinoma presenting as ground glass nodules using peri- and intra-nodular radiomic features</article-title><source>Front Oncol</source><volume>10</volume><fpage>838</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fonc.2020.00838</pub-id><pub-id pub-id-type="pmid">32537436</pub-id></element-citation></ref>
<ref id="b23-ol-27-1-14159"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Outesh</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>Y</given-names></name><name><surname>Pu</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><article-title>Radiomic-based quantitative CT analysis of pure ground-glass nodules to predict the invasiveness of lung adenocarcinoma</article-title><source>Front Oncol</source><volume>10</volume><fpage>872</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fonc.2020.608365</pub-id><pub-id pub-id-type="pmid">32850301</pub-id></element-citation></ref>
<ref id="b24-ol-27-1-14159"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>P</given-names></name></person-group><article-title>Practical explainable AI using python: Artificial intelligence model explanations using pythonbased libraries, extensions, and frameworks</article-title><publisher-name>Apress Media</publisher-name><publisher-loc>New York, NY</publisher-loc><year>2021</year></element-citation></ref>
<ref id="b25-ol-27-1-14159"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLong</surname><given-names>ER</given-names></name><name><surname>DeLong</surname><given-names>DM</given-names></name><name><surname>Clarke-Pearson</surname><given-names>DL</given-names></name></person-group><article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach</article-title><source>Biometrics</source><volume>44</volume><fpage>837</fpage><lpage>845</lpage><year>1988</year><pub-id pub-id-type="doi">10.2307/2531595</pub-id><pub-id pub-id-type="pmid">3203132</pub-id></element-citation></ref>
<ref id="b26-ol-27-1-14159"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Goo</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Wi</surname><given-names>JY</given-names></name><name><surname>Chung</surname><given-names>DH</given-names></name><name><surname>Go</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>CM</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name></person-group><article-title>Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules</article-title><source>J Thorac Oncol</source><volume>9</volume><fpage>74</fpage><lpage>82</lpage><year>2014</year><pub-id pub-id-type="doi">10.1097/JTO.0000000000000019</pub-id><pub-id pub-id-type="pmid">24346095</pub-id></element-citation></ref>
<ref id="b27-ol-27-1-14159"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs</article-title><source>Biosci Rep</source><volume>42</volume><fpage>BSR20212416</fpage><year>2022</year><pub-id pub-id-type="doi">10.1042/BSR20212416</pub-id><pub-id pub-id-type="pmid">35005775</pub-id></element-citation></ref>
<ref id="b28-ol-27-1-14159"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules?</article-title><source>PLoS One</source><volume>12</volume><fpage>e180502</fpage><year>2017</year></element-citation></ref>
<ref id="b29-ol-27-1-14159"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>SF</given-names></name><name><surname>Yin</surname><given-names>K</given-names></name><name><surname>Meng</surname><given-names>CX</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Dhupar</surname><given-names>R</given-names></name></person-group><article-title>Predicting benign, preinvasive, and invasive lung nodules on computed tomography scans using machine learning</article-title><source>J Thorac Cardiovasc Surg</source><volume>163</volume><fpage>1496</fpage><lpage>1505.e10</lpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.jtcvs.2021.02.010</pub-id><pub-id pub-id-type="pmid">33726909</pub-id></element-citation></ref>
<ref id="b30-ol-27-1-14159"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Radiomics nomogram: A noninvasive tool for preoperative evaluation of the invasiveness of pulmonary adenocarcinomas manifesting as ground-glass nodules</article-title><source>Transl Oncol</source><volume>14</volume><fpage>100936</fpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.tranon.2020.100936</pub-id><pub-id pub-id-type="pmid">33221688</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-ol-27-1-14159" position="float">
<label>Figure 1.</label>
<caption><p>Flowchart of patient selection. AAH, atypical adenomatous hyperplasia; AIS, adenocarcinoma <italic>in situ</italic>; MIA, minimally invasive adenocarcinoma; GPL, glandular precursor lesion; HRCT, high-resolution computed tomography.</p></caption>
<graphic xlink:href="ol-27-01-14159-g00.tif"/>
</fig>
<fig id="f2-ol-27-1-14159" position="float">
<label>Figure 2.</label>
<caption><p>CT images were used for accurate nodule delineation and quantitative texture feature extraction, complemented by corresponding hematoxylin-eosin stained pathological images at &#x00D7;40 magnification. (A) In the first case, a 69-year-old female had a 10&#x00D7;8 mm GGN in the upper lobe of the right lung with limited solid features. (B) In the second case, a 63-year-old female had a 9&#x00D7;7 mm GGN in the lower lobe of the right lung, mainly solid. CT, computed tomography; GGN, ground glass nodules; SV, solid volume; SVR, solid volume rate; SQ, solid quality; SQR, solid quality rate; CT<sub>max</sub>, maximum computed tomography attenuation; CT<sub>mean</sub>, mean computed tomography attenuation; HU, Hounsfield units.</p></caption>
<graphic xlink:href="ol-27-01-14159-g01.tif"/>
</fig>
<fig id="f3-ol-27-1-14159" position="float">
<label>Figure 3.</label>
<caption><p>ROC curves evaluated model performance in both the training and validation sets. The nomogram outperformed all other models, with an AUC of 0.992 in the training set and 0.975 in the validation set. ROC, receiver operating characteristic; AUC, area under the curve; SV, solid volume; SVR, solid volume rate; SQ, solid quality; SQR, solid quality rate; CT<sub>max</sub>, maximum computed tomography attenuation; CT<sub>mean</sub>, mean computed tomography attenuation.</p></caption>
<graphic xlink:href="ol-27-01-14159-g02.tif"/>
</fig>
<fig id="f4-ol-27-1-14159" position="float">
<label>Figure 4.</label>
<caption><p>The nomogram helps differentiate MIA from AIS/AAH. (A) The &#x2018;Total Points&#x2019; on the nomogram predicts the chance of MIA. (B) An AIS case had a &#x2018;Total Points&#x2019; value of 193.588, meaning a MIA probability less than 0.1. (C) An MIA case has a &#x2018;Total Points&#x2019; value of 202.369, corresponding to a MIA probability greater than 0.9. MIA, minimally invasive adenocarcinoma; AIS, adenocarcinoma <italic>in situ</italic>; AAH, adenomatous hyperplasia; SV, solid volume; SVR, solid volume rate; SQ, solid quality; SQR, solid quality rate; CT<sub>max</sub>, maximum computed tomography attenuation; CT<sub>mean</sub>, mean computed tomography attenuation.</p></caption>
<graphic xlink:href="ol-27-01-14159-g03.tif"/>
</fig>
<fig id="f5-ol-27-1-14159" position="float">
<label>Figure 5.</label>
<caption><p>The calibration curve of the nomogram model was created and evaluated in both the training and validation sets.</p></caption>
<graphic xlink:href="ol-27-01-14159-g04.tif"/>
</fig>
<table-wrap id="tI-ol-27-1-14159" position="float">
<label>Table I.</label>
<caption><p>Clinical characteristics, CT quantitative parameters and texture features between GPL and MIA groups.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Clinical characteristic</th>
<th align="center" valign="bottom">AAH/AIS (n=49)</th>
<th align="center" valign="bottom">MIA (n=62)</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Age, years, mean (SD)</td>
<td align="center" valign="top">54.26 (12.24)</td>
<td align="center" valign="top">52.84 (11.47)</td>
<td align="center" valign="top">0.646<sup><xref rid="tfn1-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">Sex</td>
<td/>
<td/>
<td align="center" valign="top">0.521<sup><xref rid="tfn2-ol-27-1-14159" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Female, n (&#x0025;)</td>
<td align="center" valign="top">33 (70.2)</td>
<td align="center" valign="top">41 (66.1)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Male, n (&#x0025;)</td>
<td align="center" valign="top">14 (29.8)</td>
<td align="center" valign="top">21 (33.9)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">MD, mm, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">7.60 (5.02&#x2013;10.00)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">8.20 (4.24&#x2013;9.87)</td>
<td align="center" valign="top">0.080</td>
</tr>
<tr>
<td align="left" valign="top">SV, mm<sup>3</sup>, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">59.00 (11.00&#x2013;128.00)</td>
<td align="center" valign="top">87.00 (0.00&#x2013;156.00)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">SVR, &#x0025;, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">38.00 (8.00&#x2013;66.00)</td>
<td align="center" valign="top">45.00 (0.00&#x2013;68.00)</td>
<td align="center" valign="top">0.021<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">SQ, mg, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">49.00 (7.00&#x2013;110.00)</td>
<td align="center" valign="top">72.00 (0.00&#x2013;128.00)</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">SQR, &#x0025;, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">29.00 (6.00&#x2013;66.00)</td>
<td align="center" valign="top">47.00 (0.00&#x2013;66.00)</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>max</sub>, HU, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">&#x2212;151.50 (&#x2212;270.00&#x2013;102.00)</td>
<td align="center" valign="top">&#x2212;111.00 (&#x2212;282.00&#x2013;62.00)</td>
<td align="center" valign="top">0.034<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>min</sub>, HU, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">&#x2212;784.50 (&#x2212;915.00&#x2013;558.00)</td>
<td align="center" valign="top">&#x2212;788.0 (&#x2212;1007.00&#x2013;582.00)</td>
<td align="center" valign="top">0.935</td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>mean</sub>, HU, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">&#x2212;584.50 (&#x2212;709.00&#x2013;348.00)</td>
<td align="center" valign="top">&#x2212;530.00 (&#x2212;737.00&#x2013;399.00)</td>
<td align="center" valign="top">0.002<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>median</sub>, HU, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">&#x2212;588.50 (&#x2212;710.00&#x2013;368.00)</td>
<td align="center" valign="top">&#x2212;546.00 (&#x2212;730.00&#x2013;419.00)</td>
<td align="center" valign="top">0.091</td>
</tr>
<tr>
<td align="left" valign="top">Variance, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">137.00 (92.00&#x2013;187.00)</td>
<td align="center" valign="top">139.00 (84.00&#x2013;194.00)</td>
<td align="center" valign="top">0.429</td>
</tr>
<tr>
<td align="left" valign="top">Kurtosis, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">3.50 (2.00&#x2013;4.80)</td>
<td align="center" valign="top">3.30 (1.90&#x2013;4.90)</td>
<td align="center" valign="top">0.797</td>
</tr>
<tr>
<td align="left" valign="top">Skewness, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.39 (&#x2212;0.19&#x2013;0.86)</td>
<td align="center" valign="top">0.48 (&#x2212;0.40&#x2013;0.78)</td>
<td align="center" valign="top">0.327</td>
</tr>
<tr>
<td align="left" valign="top">Entropy, median (range)<sup><xref rid="tfn3-ol-27-1-14159" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">5.50 (3.60&#x2013;7.30)</td>
<td align="center" valign="top">6.30 (3.20, 8.00)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn4-ol-27-1-14159" ref-type="table-fn">d</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-ol-27-1-14159"><label>a</label><p>t-test;</p></fn>
<fn id="tfn2-ol-27-1-14159"><label>b</label><p>&#x03C7;<sup>2</sup> test;</p></fn>
<fn id="tfn3-ol-27-1-14159"><label>c</label><p>continuous variables were represented as median (minimum, maximum);</p></fn>
<fn id="tfn4-ol-27-1-14159"><label>d</label><p>P&#x003C;0.05 ndicates a statistically significanct difference. HU, Hounsfifield unit; SD, stander deviation; MD, maximum diameter; SV, solid volume; SVR, solid volume rate; SQ, solid quality; SQR, solid quality rate; CT<sub>max</sub>, maximum computed tomography attenuation; CT<sub>min</sub>, minimum computed tomography attenuation; CT<sub>mean</sub>, mean computed tomography attenuation; CT<sub>median</sub>, median computed tomography attenuation.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-ol-27-1-14159" position="float">
<label>Table II.</label>
<caption><p>The AUC values for each prediction model were calculated and evaluated on both the training and validation set.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2">Training set</th>
<th align="center" valign="bottom" colspan="2">Validation set</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Clinical characteristic</th>
<th align="center" valign="bottom">AUC (95&#x0025; CI)</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">AUC (95&#x0025; CI)</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">SV, mm<sup>3</sup>)</td>
<td align="center" valign="top">0.735 (0.622&#x2013;0.848)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.547 (0.347&#x2013;0.748)</td>
<td align="center" valign="top">0.640</td>
</tr>
<tr>
<td align="left" valign="top">SVR, &#x0025;)</td>
<td align="center" valign="top">0.654 (0.529&#x2013;0.779)</td>
<td align="center" valign="top">0.021<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.540 (0.331&#x2013;0.750)</td>
<td align="center" valign="top">0.690</td>
</tr>
<tr>
<td align="left" valign="top">SQ, mg</td>
<td align="center" valign="top">0.732 (0.620&#x2013;0.843)</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.509 (0.303&#x2013;0.715)</td>
<td align="center" valign="top">0.931</td>
</tr>
<tr>
<td align="left" valign="top">SQR, &#x0025;</td>
<td align="center" valign="top">0.729 (0.611&#x2013;0.847)</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.523 (0.321&#x2013;0.725)</td>
<td align="center" valign="top">0.822</td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>max</sub>, HU</td>
<td align="center" valign="top">0.641 (0.513&#x2013;0.769)</td>
<td align="center" valign="top">0.034<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.575 (0.376&#x2013;0.775)</td>
<td align="center" valign="top">0.456</td>
</tr>
<tr>
<td align="left" valign="top">CT<sub>mean</sub>, HU</td>
<td align="center" valign="top">0.706 (0.577&#x2013;0.834)</td>
<td align="center" valign="top">0.002<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.509 (0.305&#x2013;0.721)</td>
<td align="center" valign="top">0.931</td>
</tr>
<tr>
<td align="left" valign="top">entropy</td>
<td align="center" valign="top">0.752 (0.640&#x2013;0.866)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.521 (0.318&#x2013;0.724)</td>
<td align="center" valign="top">0.835</td>
</tr>
<tr>
<td align="left" valign="top">nomogram</td>
<td align="center" valign="top">0.992 (0.980&#x2013;1.000)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.975 (0.935&#x2013;1.000)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn5-ol-27-1-14159" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn5-ol-27-1-14159"><label>a</label><p>P&#x003C;0.05 indicates a statistically significanct difference. AUC, area under the curve; CI, confidence interval; HU, Hounsfifield unit; SV, solid volume; SVR, solid volume rate; SQ, solid quality; SQR, solid quality rate; CT<sub>max</sub>, maximum computed tomography attenuation; CT<sub>mean</sub>, mean computed tomography attenuation.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-ol-27-1-14159" position="float">
<label>Table III.</label>
<caption><p>Performance of nomogram model on the training and validation set.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Set</th>
<th align="center" valign="bottom">AUC</th>
<th align="center" valign="bottom">95&#x0025; CI</th>
<th align="center" valign="bottom">Sensitivity</th>
<th align="center" valign="bottom">Specificity</th>
<th align="center" valign="bottom">Accuracy</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Training</td>
<td align="center" valign="top">0.992</td>
<td align="center" valign="top">0.980&#x2013;1.000</td>
<td align="center" valign="top">0.907</td>
<td align="center" valign="top">1.000</td>
<td align="center" valign="top">0.948</td>
</tr>
<tr>
<td align="left" valign="top">Validation</td>
<td align="center" valign="top">0.975</td>
<td align="center" valign="top">0.935&#x2013;1.000</td>
<td align="center" valign="top">0.842</td>
<td align="center" valign="top">0.941</td>
<td align="center" valign="top">0.912</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn6-ol-27-1-14159"><p>AUC, area under the curve; CI, confidence interval.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
